Nuveen
NVO

Nuveen’s Novo Nordisk NVO Stock Holding History

Nuveen’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142M Buy
+2,969,256
New +$128M 0.03% 347
2025
Q3 		– Sell
-2,095,758
Closed -$145M – 3291
2025
Q2 		$145M Sell
2,095,758
-3,236,504
-61% -$220M 0.04% 311
2025
Q1 		$370M Sell
5,332,262
-912,669
-15% -$75.4M 0.11% 161
2024
Q4 		$537M Buy
6,244,931
+2,639,693
+73% +$285M 0.15% 116
2024
Q3 		$429M Buy
3,605,238
+86,242
+2% +$11.5M 0.12% 146
2024
Q2 		$502M Sell
3,518,996
-153,290
-4% -$20.3M 0.15% 120
2024
Q1 		$472M Buy
3,672,286
+525,211
+17% +$62.5M 0.14% 131
2023
Q4 		$326M Sell
3,147,075
-41,389
-1% -$4.09M 0.1% 170
2023
Q3 		$290M Buy
3,188,464
+22,982
+0.7% +$2.02M 0.1% 180
2023
Q2 		$256M Buy
3,165,482
+850,078
+37% +$69.4M 0.09% 184
2023
Q1 		$184M Buy
2,315,404
+933,614
+68% +$66.2M 0.07% 243
2022
Q4 		$93.5M Buy
+1,381,790
New +$81M 0.04% 378
2022
Q1 		– Sell
-113,654
Closed -$6.37M – 3411
2021
Q4 		$6.37M Sell
113,654
-27,254
-19% -$1.48M ﹤0.01% 1973
2021
Q3 		$6.76M Sell
140,908
-6
-0% -$290 ﹤0.01% 2055
2021
Q2 		$5.9M Hold
140,914
– – ﹤0.01% 2164
2021
Q1 		$4.75M Buy
140,914
+646
+0.5% +$23K ﹤0.01% 2197
2020
Q4 		$4.9M Sell
140,268
-362
-0.3% -$12.5K ﹤0.01% 2089
2020
Q3 		$4.88M Sell
140,630
-434
-0.3% -$14.5K ﹤0.01% 1925
2020
Q2 		$4.62M Sell
141,064
-538
-0.4% -$17.2K ﹤0.01% 1937
2020
Q1 		$4.26M Sell
141,602
-272
-0.2% -$8.1K ﹤0.01% 1804
2019
Q4 		$4.11M Buy
+141,874
New +$3.93M ﹤0.01% 2093

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Nuveen's NVO Position: Q2 2026 in Review

Nuveen opened a new position in Novo Nordisk (NVO) in Q2 2026: 2,969,256 shares worth $142M. The stake represents 0.03% of the portfolio and ranks #347 among its holdings. This is a return to the name: Nuveen previously reported a position in NVO as recently as Q2 2025.

Nuveen first reported a position in NVO in Q4 2019 and has held it in 21 quarters since. The position peaked at $537M in Q4 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Nuveen held 2,969,256 shares of Novo Nordisk worth $142M as of Q2 2026.
  • Novo Nordisk was a new Nuveen position in Q2 2026.
  • Novo Nordisk made up 0.03% of Nuveen's portfolio in Q2 2026, its #347 holding.
  • Nuveen first reported a position in Novo Nordisk in Q4 2019 and has held it in 21 quarters since.
  • Nuveen's Novo Nordisk position peaked at $537M in Q4 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.